Background: Local recurrence rates after curative rectal resection for rectal cancer have decreased after introduction of tme. in order to achieve even further reduction in local recurrence rates, several hospitals increase the use of preoperative radiotherapy.t hus, radiotherapy-related side effects will increase. the aim of the study was to evaluate the results of the tme-technique with minimal use of radiotherapy.
INTRODUCTION
After the introduction of total mesorectal excision (TME), local recurrence rates after rectal cancer surgery have been reduced to 5-10% compared to 20-efit in centres with low local recurrence rates after surgery alone still has to be proven (6) (7) (8) (9) (10) (11) (12) (13) (14) . The aim of the study was to examine the effect of surgery alone on local recurrence rate and survival.
MATERIAlS AND METHODS
From 1993 until2 000, 137 consecutive patients treated for rectal cancer at the Department of Surgery,Nordland Hospital, Bodø,w erep rospectively registered in ad atabase. Between 18 and 22 patients wereadmitted annually from a stable population in agiven geographical area.
Therectum was defined up to 16 cm from the anal verge measured with arigid sigmoidoscope. The level of tumour was determined in the same procedure. Preoperative local staging was done by endoscopy and digital examination. Plain chest films and ultrasonography of the liver/abdomen wereu sed to detect distant metastases. In the late 90ties CT scan wereincreasingly used. Magnetic resonance imaging (MRI) was not available. All patients wereo perated according to TME principle of anatomical dissection (15, 16) , which was introduced in Norway in 1993. If tumour extended beyond the mesorectum the dissection was moreextensive than the mesorectal demarcation to achieve free CRM. Wide excision through the pelvic floor in abdomino-perineal resections (APR) was performed to achieve free CRM. "High tie" on the inferiormesenteric artery was achieved. The rectum was routinely cleaned with saline befores tapling of the anastomosis. All anastomoses were tested with insufflations of air.
Patients with clinical and histopathological R0 and R1-resections and patients with operable distant metastases were operated with intention to cure. Patients with per-operative perforation of the rectum wereincluded in curative group. Tumour growth into other organs was resected èn bloc, and considered curative.
Patients with R2 resections, with non-curable distant metastases,n on-resectablet umours and patients with local treatment werei ncluded in the palliative group. Covering stoma was not ar outine, but was determined by the operator.
Patients with clinically fixed rectal tumours received preoperative radiotherapy with two Gy-fractions each day for 25 days (2 Gy × 25). Chemotherapy wasn ot used in these patients. Patients with pR1-resections received postoperative radiotherapy (2 Gy × 25). In patients with per-operative rectal perforation, postoperative radiotherapy was considered. Chemotherapy was offered patientsi nap alliative situation.
The tumours wereclassified according to the Dukes stage and the TNM classification. local recurrences weredefined as recurrences inside the pelvis or in the perineum, includinganastomotic recurrences, with or without concomitant metastasis. Metachronous intraluminar malignancy,pelvic bone metastasis or recurrences in the groin weren ot considered as local recurrence.
All patients wereobserved for at least 60 months or until death. Patients under age of 75 years and fit older patients accessible for resection of metastases had an outpatients visit every three months for two years, every six months the thirdyear,and yearly up to five years postoperatively.The controls included CEA-levels, chest films, ultrasonography of the liver and rigid sigmoidoscopy.C oloscopy was performed perioperatively and five years after surgery.V ery old or otherwise frail patients werenot reviewed for control regularly.Medical history was obtained when admitted for cancer recurrence, other diseases or death. All patients are thus accounted for.
STATISTICS
Fisher exact test and Pearsons chi-squaret est were used to test differences in proportions. Mann-Whitney Utest wereused to test differences between medians. The prognostic significance of selected factors for local recurrence was tested using the Cox proportional hazardr egression model. Survival analyses wereperformed by Kaplan Meyer estimates. P<0.05 was considered to be significant. All analysis was performed using Statistical Package for Social Science  program (SPSS, Chicago, Illinois. USA)
RESUlTS
Patients, treatment and tumour characteristics are given in Table 1 . In the curative group therewere115 patients (84%), in the palliative group 22 (16%). Four patients died postoperatively (3%), two in each group. One hundred and thirty-three patients (97%) had rectal resections. Three patients underwent diverting stoma only,and one had alocalresection. Incurative group, dissection extended beyond the "holy plane" (16) in six patients to obtain radical CRM. Thirtyseven patients (32%)inthe curative group had acovering stoma. Am edian of eight lymph nodes (0-21 lymph nodes) wered etected in the surgical specimens.
Anastomotic leakages wered iagnosed in four patients, three in the curative group, and one after palliative surgery.Three werere-operated and one died due to septicaemia. One patient received only antibiotic treatment.
Twop atients had synchronous single liver metastasis resected at the primary operation. Adjacent urinary bladder wall (one patient); prostate (one patient), small bowel (one patient) and enlarged lymph nodes cranial to the inferior mesenteric artery (one patient) werer esected èn bloc during the primary surgery.
Five patients had fixed tumours assessed by clinical examination and received preoperative radiotherapy (3%). Twoended up in the palliative group: one had aR 2r esection and one had only as toma. Four patients with pR1 resection and one of seven patients with per-operative rectal perforation received postoperative radiotherapy.Thus, eight of the 115patients (6.9%) in the curative group received perioperative radiotherapy.
local recurrence developed in six patients (4,3%), four in the curative group (3,4%) and two in the palliative resection group (10%). In the palliative group therew ere1 1p atients (50%) with T4 tumours; two had ap R1 resection and five ap R2 resection. In the curative group two of the local recurrences had a clinical fixed tumour and ap R1 resection. Patient, treatment and tumour characteristics in patients with local recurrence in the curative group areg iven in Table 2 . One patient underwent pelvic exenteration, with recurrence and death after 72 months. Twohad inoperable distant metastasis and one was frail.
In univariate analyses, local recurrence was associated with fixed tumour (p =0.008), tumour size (p =0.01), clinical R1-resection (p <0.003), pR1 (CRM less than 1,0 mm) (p =0,005) and Dukes C(p=0,001). Despite preoperative radiotherapy,f our of the five patients with fixed tumoursdied from their primary cancer.I naC ox proportional hazardr egres-sion model these factors did not predict local recurrence.
New intraluminal rectal tumours werediscovered at the three-year follow-up in two patients in the curative group. The tumours whereb oth Dukes Ba nd weresuccessfully resected. These tumours werecon-sidered as metachronous. The patients ares till alive after morethan 10 years.
Sixteen patients (15%) in the curative group developed distantmetastases in the liver (nine), lung (six), lymphnodes (five) or miscellaneous (four). In four patients surgery was performed: two liver resections, one lung resection, and one liver +lung resection. Figure 1s hows total survival for patients in the curative and the palliative group. In the curative group, at otal of 30 patients died during the 60 
DISCUSSION
The results in the present study show al ow recurrence rate and af air survival rate with minimal use of pre-or postoperative radiotherapy.T he curative rate is high. We particularly evaluated our data-basis for these results. The data-basis for survival-and local recurrence rates differs between various studies. This makes comparison between studies difficult (4, 17). In hospital series, bias is ac oncern (12) . In national population based studies operative method, performance and variation in reporting frequencies and observational time may be biased (18) . Rates for both the curative and the palliative groups should be reported, as well as the rate of resection. Otherwise, the Will-Rogers phenomena, which is migration between groups, will arise (12, 13, 18) . To achieve reliable data for recurrence andsurvival rates, at least 80% of the patients should have passed the end-point of observation for the study (19, 20) . In Patients at risk (alive) 22 11 62111 the present study,all patients have been observed for at least 60 months or until death. This material is comparable to the national epidemiological study according to patient and tumour characteristics( 18,2 1). The materiali sp opulation based and our results should thereforeberepresentative. In univariate analysis known risk factors are significant in the present study,but in aCox proposal hazardm odel the factors did not reach significance. This may be due to small number and the heterogeneity within Dukes' and Tstages.
Definitions of "intention to cure" vary among studies. We use aw ide definition to measuret he effect of the technique and the performance. With less inclusive definitions, some curable patients will be allocated to the non-curable, not evaluable group or excluded from the study (12) . Rates below 70% of "intention to cure" may lead to false low recurrence rates, since patients at highest risk for local recurrence may be excluded. Short observation time may also lead to false low recurrence rates (11, 19, 20) , especially when adjuvant treatment can postpone recurrence.
Twop atients developed new intraluminar adenocarcinoma in the colonic part inside the pelvis considered as metachronous cancer coli. Metachronous tumours ares eldom, but exist (22, 23) . Both were easily resected, which is not the case in true local recurrences.
The definition of rectum may influence local recurrence rates. In the presentstudy local recurrence rates werealmost identical using both 12 and 15 cm above the anal verge. In the present study,both clinical and pathologicalR1resection was associated with higher recurrence rates, confirmed by others (9, 18).
Enker et al. published local recurrence rates of 7,3% in Dukes Ba nd Cp atients with ar ectal length of 12 cm (2). Heald published local recurrence rates of 3,7%, but excluded APR and defined arectum length of 15 cm (1). Using the same inclusion criteria in the present study corresponding rates are3,6% and 3,5 % respectively.
Several authors chooses to exclude patients with distant metastases from the "intention to cure" groups (18, 20) , as well as patients with peroperative rectal perforation (3, 4). Others exclude fixed tumours (8, 11) . Taking this into account, local recurrence rates in this study remains below 5%. The low recurrence rate interpreted as local control is the effect of the surgical technique in this study.
The effect of the operative method itself can only be evaluated when both the survival and local recurrence rate arec onsidered. In ap rospective randomised multicentres tudy comparing TME (TMEgroup) and preoperative radiotherapy and subsequent TME (RTx +TME) (8, 11)the five years risk of local recurences were1 0,9 %a nd 5,6 %r espectively. The difference was significant. Survival rate was not different; 63,5 % and 64,2 % respectively (8). Inclusion criteria werep atients with mobile tumours, macroscopically free CRM-margin, and no distant metastasesnor additional malignancies. The rectum was defined to 15 cm from the anal verge. Applying this criterion on our material it consists of 106 patients without preoperative irradiation. The local recurrence rate was 2,2% with asurvival rate of 74 %compared to 10,9% and 64,5% in the reported study (8) .
Several large multicentrestudies now report local recurrence rates below 15% (8, 9, 18, 24, 25) . The discrepancy between these results and the results from other series remains to be accounted for (1, 2, 3, 4, 23) . Results for the Norwegian Rectal Cancer Group show local recurrence rates of 13-16%, with improving 5years survival since the TME-technique was introduced in 1993 (9, 18, 21) . On the other hand anumber of Norwegian hospitals have recurrence rates far below 10% with little use of preoperative radiotherapy (3, 26, 27, 28) . Based on international studies and recent results from the national audit the use of preoperative radiotherapy has increased in Norway from 4,6% to 23%. The local recurrence rates have decreased from 16,2% to 10,7% (9). The study of Hansen et al. (9) states that preoperative radiotherapy is the most important single factor responsible for the reduction. Although it seems likely that preoperative treatments have effect in studies with high local recurrence rate (6), it remains to be shown that preoperative radiotherapy,with or without chemotherapy has effect in patients operated in hospitals with low recurrence rates far below 10% (4), especially when the side-effects of radiotherapy areaccounted for.In the present study surgery alone seems to be sufficient.
In astudy of 53 patients with curative resection of T3 or T4, pR0 tumours in the middle and lower rectum, Wheeler et al. studied the effect of preoperative chemo radiotherapy (29) . Staging was done prior to adjuvant treatment. After amedian observation of 39 months, 5,8% developed local recurrence, and the total survival rate was 67%. Acorresponding group in our study consists of 78 patients with pT3 or pT4, pR0 tumours, with afi ve years local recurrence rate of 3,8% (3/78) and atotal survival rate of 74%. Only three of these 78 patients (2,5%) received preoperative radiation.
According to the updated Norwegian guidelines, neoadjuvant chemoradiotherapy is now given to patients with T4 tumours or aC RM of less than three mm at the preoperative MR-study.T hese guidelines imply ar ate of neoadjuvant chemoradiotherapy of about 30%. Applied on the patients in the present study,about 30-40 patients would have received neoadjuvant therapy.The low rate of local recurrence in the present study would most likely have been interpreted asaneffect of the neoadjuvant treatment and not as an effect of surgery alone. Of the four patients with local recurrences, two did not receive preoperative radiotherapy.They might possibly have had benefit from radiotherapy.T wo of the three patients who received preoperative radiotherapy,however,had no benefit.
Clinically fixed tumours and T4 tumours should be offered preoperative treatment to enhance the chance to be included in the curative group. The challenge may thereforeb et od efine other subgroups for preoperative down-staging in order to increase the curative rate, maintain low recurrence rate and hopefully increase total survival.
In conclusion, the present study demonstrates that it is possible to achieve low recurrence rates and high survival rates after surgery alone with minimal use of neoadjuvant radiotherapy.Itremains to be shown that neoadjuvant radiotherapy has beneficial effects in patients operated in hospitals with low recurrence rates.
